• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

AERS Patient Outcomes by Year

(As of December 31, 2010) Back to AERS Statistics Main Page

These data describe the outcome of the patient as defined in U.S. reporting regulations (21 CFR 310.305, 314.80, 314.98, 600.80) and Forms FDA 3500 and 3500A (the MedWatch forms). Serious means that one or more of the following outcomes were documented in the report: death, hospitalization, life-threatening, disability, congenital anomaly and/or other serious outcome. Documenting one or more of these outcomes in a report does not necessarily mean that the suspect product(s) named in the report was the cause of these outcomes.


This figure illustrates the patient outcome(s) for reports in AERS since the year 2000 until the end of 2010. Serious outcomes include death, hospitalization, life-threatening, disability, congenital anomaly and/or other serious outcome.

Patient outcome(s) for reports in AERS since the year 2000. Corresponding data appear in the accompanying table.


This figure illustrates the patient outcome(s) for reports in AERS since the year 2000 until the end of 2010. Serious outcomes include death, hospitalization, life-threatening, disability, congenital anomaly and/or other serious outcome.

Year Death Serious
2000 19,445 153,818
2001 23,988 166,384
2002 28,181 159,000
2003 35,173 177,008
2004 34,928 199,510
2005 40,238 257,604
2006 37,465 265,130
2007 36,834 273,276
2008 49,958 319,741
2009 63,846 373,535
2010 82,724 471,291
-
-